Serva Health Insights
Welcome to the Serva Health Blog—your destination for insights on patient engagement, clinical trial support, and biopharma commercial services. Our insights are designed to provide valuable information and expert perspectives on how to enhance patient care, streamline clinical trial processes, and navigate the complexities of healthcare. Here, you’ll find articles that explore the latest trends in patient support strategies, innovative healthcare technologies, and best practices for optimizing patient outcomes. Stay informed with Serva Health as we continue to shape the future of healthcare services.
The technology behind any Patient Support Program (PSP) does more than just check boxes. It sets the tone for how patients, providers, and support teams interact, often over months or years of treatment. Yet with so many digital options available, picking the right platform can feel like navigating a maze
Clinical trials are the backbone of medical research, but their success hinges on efficient communication, participant engagement, and careful coordination among stakeholders. Unfortunately, many trials struggle with these aspects. 85% of trials fail to recruit enough participants and 80% fail to meet enrollment timelines, and dropout rates can exceed 30%.
Launching a patient support program in biopharma is a significant milestone, but it’s not the finish line. The real work starts the moment the first patient is enrolled. Those first few weeks are where make-or-break moments happen; onboarding, access, education, and the emotional experience of starting a complex therapy. To
Biomedical research is about pushing the boundaries of human knowledge, today those breakthroughs rely as much on digital infrastructure as they do laboratory innovation. Data sets that once lived in secured file rooms now exist in interconnected platforms, shared across collaborators, cloud environments, and connected devices. While this has accelerated
Recruiting for a rare disease study is like searching for a needle in a haystack, blindfolded. Eligible patients are few, scattered, and often heavily reliant on their trusted healthcare providers. That’s why increasing HCP referrals in rare disease clinical trials isn’t just helpful. It’s essential. Let’s explore some smarter, more
Patient expectations have changed. From ordering groceries to managing appointments, digital convenience is now the norm. That shift doesn’t stop at healthcare, especially when it comes to how patients interact with the support programs designed to help them manage complex therapies. For biopharma companies, this means evolving patient support strategies